Search

Your search keyword '"Anti-HIV Drugs"' showing total 123 results

Search Constraints

Start Over You searched for: Descriptor "Anti-HIV Drugs" Remove constraint Descriptor: "Anti-HIV Drugs" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
123 results on '"Anti-HIV Drugs"'

Search Results

Catalog

Books, media, physical & digital resources

3. Adaptation of the REINVENT neural network architecture to generate potential HIV-1 entry inhibitors

4. Formulation and characterization of liposomes containing drug absorption enhancers for optimized anti-HIV and antimalarial drug delivery.

5. Evaluation of COVID-19 protease and HIV inhibitors interactions

6. Anti-HIV drugs lopinavir/ritonavir activate bitter taste receptors.

8. Current status of the small molecule anti-HIV drugs in the pipeline or recently approved.

9. 2016—2020年我院门诊艾滋病抗病毒药使用情况分析.

10. Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities

11. Gaps and solutions of HIV testing, care, and treatment in Iran during 2018-2019.

12. Stability Indicating Analytical Method for Estimation of Related substances of Anti-HIV Drugs in Fixed dose Tablet Formulation by RP-HPLC.

13. Eficacia y seguridad en condiciones clínicas reales del raltegravir en un hospital de referencia del seguro social peruano.

14. Oral environment and taste function of Japanese HIV-infected patients treated with antiretroviral therapy.

15. LDH hybrid thermosensitive hydrogel for intravaginal delivery of anti-HIV drugs.

16. Evaluation of COVID-19 protease and HIV inhibitors interactions

17. HIV - recentes avanços na pesquisa de fármacos HIV - highlights in drug research

18. Efetividade da terapia anti-retroviral dupla e tríplice em crianças infectadas pelo HIV Effectiveness of dual and triple antiretroviral therapy in the treatment of HIV-infected children

19. Computer-aided discovery of anti-HIV agents.

20. Repurposing of the anti-HIV drug emtricitabine as a hydrogen-bonded cleft for bipyridines via cocrystallization

21. The structural effect on volumetric and acoustic properties of aqueous anti-HIV drugs (Emtricitabine and Lamivudine) at various temperatures.

22. 基于专利计量分析的抗 HIV 药物发展趋势研究.

23. Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment

24. HIV Patients Have Impaired Diastolic Function that is Not Aggravated by Anti-Retroviral Treatment.

25. Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route.

26. Quantitative structure-activity relationship studies of diarylpyrimidine derivatives as anti-HIV drugs using new three-dimensional structure descriptors.

29. Determination of the Anti‐HIV Drug Nevirapine Using Electroactive 2D Material Pd@rGO Decorated with MoS 2 Quantum Dots

30. NCp7: targeting a multitask protein for next-generation anti-HIV drug development part 2. Noncovalent inhibitors and nucleic acid binders

31. Computational analysis of CYP3A4-mediated metabolism to investigate drug interactions between anti-TB and anti-HIV drugs in HIV/TB co-infection.

32. Uninformative variable elimination assisted by Gram–Schmidt Orthogonalization/successive projection algorithm for descriptor selection in QSAR.

33. Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases.

34. Lamivudine salts with improved solubilities.

35. A Potential In Vitro and In Vivo anti-HIV Drug Screening System for Chinese Herbal Medicines.

36. HIV-1 protease inhibition potential of functionalized polyoxometalates

37. Current insights into anti-HIV drug discovery and development: a review of recent patent literature (2014–2017)

38. Virologic and Immunologic Effectiveness of Tipranavir/Ritonavir (TPV/r)- Versus Darunavir/Ritonavir (DRV/r)-Based Regimens in Clinical Practice.

39. Eastern extension of azoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase; cyano group alternatives

40. Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs

41. Comparative description of haplotype structure and genetic diversity of MDR1 (ABCB1) in HIV-positive and HIV-negative populations

42. Validation and clinical application of a high performance liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the quantitative determination of 10 anti-retrovirals in human peripheral blood mononuclear cells

43. Simultaneous determination of maraviroc and raltegravir in human plasma by HPLC-UV.

44. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs

45. Modulation of heme and myristate binding to human serum albumin by anti-HIV drugs.

46. Dissolution test for lamivudine tablets: Optimization and statistical analysis

47. Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase

48. Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin.

49. Binding of Anti-HIV Drugs to Human Serum Albumin.

50. HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches